IRCT20100228003449N28已完成2 期
Evaluating efficacy and safety of interferone ß-1a in the treatment COVID-19 infection
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Patients with highly suspected or confirmed COVID-19 infection who are candid forhospitalized and starting triple-drug combination
排除标准
- •History of drug allergy
- •Uncontrolled baseline diseases including neuropsychiatric disorders, diabetes, thyroid disorders, heart disease
- •Pregnancy and lactation
- •Baseline liver failure
研究者
相似试验
招募中
2 期
Interferon ß in treatment of COVID-19IRCT20100228003449N27Tehran University of Medical Sciences30
招募中
3 期
Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19COVID-19.Covid-19U07.1IRCT20080901001165N53Bagheiat-allah University of Medical Sciences100
招募中
不适用
Analysis of efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000018759Kyoto University Hospital50
招募中
3 期
Efficacy and safety of Interferon beta-1-a in mild to moderate COVID-19IRCT20120703010178N25Shahid Beheshti University of Medical Sciences100
已完成
不适用
Short term Efficacy and Safety of Alpha Interferon -2b (Pasture Made) plus Ribavirin for Treatment of the Patients with Chronic Hepatitis CChronic Hepatitis C.Chronic viral hepatitis CIRCT138812123307N4Pasteur Institute of Iran (IPI)100